One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in financing and a promise of creating 100 jobs within five years. Monday’s announcement is a […]
MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based in Gaithersburg and will focus on inflammation and autoimmunity biologics, targeting pathways that are the root of disease. The company said it plans to create […]
Johns Hopkins University is launching a new Ph.D program that will offer students hands-on work experience in the biopharmaceutical field, where they’ll learn about the process of discovering and developing new drugs. Officials say the partnership between the university and MedImmune, a company that focuses on biologics – prescription medicines developed from biological sources – […]
FREDERICK — The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business. The Frederick News-Post reports that the Board of Aldermen voted Thursday to approve a series of agreements between the company, the city and the State Highway Administration to […]
FREDERICK — The Frederick County Council has voted to financially support the expansion of MedImmune’s Frederick manufacturing plant, a project the company says will bring 300 new jobs. The Frederick News-Post reports that, in a 6-1 vote, the County Council on Tuesday approved the county’s $3.8 million contribution to a $6.8 million conditional loan for […]
Gaithersburg-based MedImmune, the biologics research and development arm of AstraZeneca, has been certified by the Department of Energy’s Superior Energy Performance program for improvements at its headquarters facility. MedImmune is the first company in Maryland to achieve the certification, the firm said. Under its management program, MedImmune improved energy performance by 8.54 percent in [...]
Gaithersburg-based MedImmune is expanding its recently announced research partnership with the University of Maryland, Baltimore to include two more UM campuses: College Park and Baltimore County.
Gaithersburg-based MedImmune has entered into a three-year partnership with the Clinical and Translational Science Institute at the University of California, San Francisco.
The University of Maryland, Baltimore and MedImmune Inc., of Gaithersburg, a subsidiary of British drug maker AstraZeneca PLC, announced they have entered into a five-year, $6 million agreement to work on novel bioscience research in Maryland.
TRENTON, N.J. — Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization. The cuts, meant to reduce costs and make research programs more productive, come just weeks after the company reported big drops […]
Bahija Jallal, Ph.D., executive vice president of research and development at MedImmune, has been named to the board of directors of the UM Health Sciences Research Park Corp. Jallal is a member of MedImmune’s executive team and of the research and development leadership team of parent company AstraZeneca. She oversees research, development, regulatory and clinical […]
Gov. Martin O’Malley will embark on a trade mission to India, the first by a sitting Maryland governor, at the end of November with a delegation of more than 100 educators, business executives and elected officials, his office announced Tuesday. The trip will stretch from Nov. 28 to Dec. 4 and include a short stop […]